Author:
Barnes Michael R.,Harland Lee,Foord Steven M.,Hall Matthew D.,Dix Ian,Thomas Scott,Williams-Jones Bryn I.,Brouwer Cory R.
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference43 articles.
1. Garnier, J. P. Rebuilding the R&D engine in big pharma. Harv. Bus. Rev. 86, 68–70, 72–76, 128 (2008).
2. Kola, I. The state of innovation in drug development. Clin. Pharmacol. Ther. 83, 227–230 (2008).
3. Ledford, H. When there's no room to grow. Nature 454, 144–145 (2008).
4. Woodcock, J. & Woosley, R. The FDA critical path initiative and its influence on new drug development. Annu. Rev. Med. 59, 1–12 (2008).
5. Schieppati, A., Henter, J. I., Daina, E. & Aperia, A. Why rare diseases are an important medical and social issue. Lancet 371, 2039–2041 (2008).
Cited by
75 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献